Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2013

Apr 29, 2013

5262_dirs_2013-04-29_ac86a01b-a422-4723-9340-201410cc2ae0.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5291D

GlaxoSmithKline PLC

29 April 2013

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline Performance Share Plan (PSP) notified the Company and the under-mentioned persons on 29 April 2013 of an increase in their interests in Ordinary Shares.

The following shares were released and were sold to meet tax liabilities as a result of the reinvestment of dividends paid on PSP awards which vested on 26 April 2013.

Ordinary shares released Number of Ordinary Shares sold to meet tax liabilities
Mr R Connor 11 6
Mr P Thomson 9 5
Dr P Vallance 297 140
Ms E Walmsley 381 180
Mr C Weber 48 0
Mrs V Whyte 9 5

The Company and PDMRs were advised of these transactions on 29 April 2013.      

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

29 April 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSDKLFLXZFBBBV